surmount studies tirzepatide surmount-1 non-diabetic obesity trial For the first time, and semaglutide were put in SURMOUNT-1 (NEJM 2022) tested tirzepatide
Pay in 4 interest-free payments of $6.13 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 15 - Nov 20



























